Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.23 +0.28 (+1.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Deferred Taxes (2022)

Updated

Cullinan Therapeutics' Deferred Taxes was -$19.57 million in Q1 2022.

Analysis

Cullinan Therapeutics (CGEM) Deferred Taxes (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -479.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -195.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -19.57 Mn
API Access

Cullinan Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=CGEM&period=max&api_key=YOUR_API_KEY